Columbia researchers have used blockchain technology to build a system that can securely store, share, and analyze genetic and clinical data for precision medicine research.
A “loopy” discovery in bacteria is raising fundamental questions about the makeup of our own genome. And revealing a potential wellspring of material for new genetic therapies.
Researchers at Columbia University College of Dental Medicine have engineered exosomes to carry CRISPR, significantly enhancing the delivery of genome editing components to specific cells and tissues.
Director of the National Cancer Institute, Harold Varmus, MD'66, talked about the challenges and goals of precision medicine's efforts to tackle cancer.
Kevin L. Gardner, MD, PhD, has been named senior vice chair of the Department of Pathology and Cell Biology and professor of pathology and cell biology.